Please assess the completion status of the following clinical trial:

Trial Title: Reduction of Bacteriuria in Subjects Practicing Intermittent Catheterization

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of informed consent~* Female/male aged 18 years and over~* Practicing intermittent catheterization at least 4 times daily for at least 6 weeks~* A minimum of 104 CFU of bacteriuria~Exclusion Criteria:~* Ongoing, symptomatic UTI at enrollment~* Known urethral stricture~* Basic tumorous disease~* Previous prostate surgery~* Subjects known to be immunocompromised e.g. HIV or diabetes~* Treatment with antibiotics and/or intravesical antiseptics for the past 30 days before study start~* Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study site)~* Pregnancy or breast feeding~* Previous enrolment or randomisation of treatment in the present study~* Participation in a clinical study that possibly might interfere with the present study, as deemed by the investigator~* Severe non-compliance to protocol as judged by the investigator and/or Astra Tech

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Catheter A (Type: EXPERIMENTAL): Catheterization with Catheter A, which releases silver ions into the urethra and urinary bladder upon catheterization,.~After activation in the wetting solution the coating retains water creating a smooth liquid surface around the catheter.The products are intended for single use. No additional lubricant were used.~The subject will be treated with investigational products during 24 hours. During this period the subject will be catheterized with the study catheter at six occasions (every 4 hours).
- Catheter B (Type: EXPERIMENTAL): Catheterization with Catheter B, which releases both silver ions and degradable silver particles.. After activation in the wetting solution the coating retains water creating a smooth liquid surface around the catheter.The products are intended for single use. No additional lubricant were used.~The subject will be treated with investigational products during 24 hours. During this period the subject will be catheterized with the study catheter at six occasions (every 4 hours).

Based on this trial design, predict the completion outcome and termination type (if applicable).